A record of what Mayuresh Joshi said publicly, with the source. Not advice.
Pending — not yet graded
“Pharma sector, which has been beaten down due to US export concerns, might see a smart bounce back. Joshi believes the rhetoric on pharmaceuticals will not play out as feared, offering respite for Indian exports given India's large number of FDA-approved facilities and the high cost of drug development, which would ultimately pinch US consumers if disproportionately taxed.”
Nifty PharmaBullishCalled 02 Apr 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Mayuresh Joshi’s full track record